Status: Recruiting
A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure
This study aims to evaluate the effectiveness and safety of ALDP001 Nasal Spray in treating seasonal allergic rhinitis, and to identify the optimal dosage and administration frequency for this formulation.
Participants needed: 164
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Alixer Nexgen Therapeutics LimitedUpdated: Oct 22, 2025Locations: 1
Eligibility criteria
Diagnosis of Allergic Rhinitis (AR), as determined by the presence of seasonal r... [+2]
Nasal abnormalities likely to affect the outcome of the study, i.e. nasal septal... [+4]